COMMUNIQUÉS West-GlobeNewswire

Proteon Therapeutics Announces Third Quarter 2018 Financial Results

07/11/2018 - 14:00

WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]

Rhythm Pharmaceuticals to Present at Stifel 2018 Healthcare Conference

07/11/2018 - 14:00

BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

The Joint Corp. Appoints Jake Singleton CFO

07/11/2018 - 14:00

SCOTTSDALE, Ariz., Nov. 07, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced its board of directors has appointed its Corporate [...]

MediPharm Labs Corp. Completes Major Extraction Milestone

07/11/2018 - 14:00

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “ Company ” or “ MediPharm Labs ”) is pleased to announce that it has reached a significant milestone by completing the purification and [...]

CareDx to Participate in Upcoming Investor Conferences

07/11/2018 - 14:00

BRISBANE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Allena Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

07/11/2018 - 14:00

-- Global Phase 3 URIROX-1™ Trial Ongoing; Expect to Initiate Second Phase 3 Study, URIROX-2™, in 2018 -- -- Presented Preclinical Proof-of-Concept Data on ALLN-346 at American College of Rheumatology (ACR/ARHP) Annual [...]

Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference Call

07/11/2018 - 14:00

LAVAL, Quebec, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST) (the “Company” or “Acasti”), a biopharmaceutical innovator focused on the research, development and commercialization of [...]

SeeThruEquity Initiates Coverage on HempAmericana

07/11/2018 - 14:00

NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is proud to announce that SeeThruEquity has initiated coverage on the Company with a [...]

IntelGenx Announces Definitive Agreement with Tilray® to Form an Exclusive, Worldwide Partnership for Cannabis-Infused VersaFilm™ Products

07/11/2018 - 14:00

SAINT LAURENT, Quebec, Nov. 07, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced the execution of a definitive license, development [...]

Xeris Pharmaceuticals Announces Third Quarter 2018 Financial Results and Highlights Pipeline Progress

07/11/2018 - 14:00

Glucagon pen NDA accepted for review by FDA Continuing to execute commercial build and launch readiness for glucagon pen Advancing pipeline of preclinical and clinical development-stage products CHICAGO, Nov. 07, 2018 ( [...]

CytomX to Present at the Jefferies 2018 London Healthcare Conference

07/11/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]

Affimed Reports Financial Results for Third Quarter 2018 and Operational Progress

07/11/2018 - 13:31

- Established strategic collaboration agreement with Genentech for NK cell engager-based immunotherapeutics: Received $96 million in upfront and committed funding, may be eligible to receive up to additional $5 billion [...]

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2019 Financial Results on November 12, 2018

07/11/2018 - 13:30

Financials for Second Quarter Fiscal Year 2019 Ended September 30, 2018 will be released November 9, 2018 NORTHVALE, N.J, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: [...]

Homology Medicines Presents Data on Platform’s Ability to Target the Central and Peripheral Nervous System and Therapeutic Potential in the Rare Disease Metachromatic Leukodystrophy

07/11/2018 - 13:30

Homology to Nominate a Clinical Development Candidate for MLD This Quarter and to Begin IND-Enabling Studies in 2019 BEDFORD, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic [...]

Integrated Cannabis Company, Inc. Signs Definitive Agreement with Empower Clinics Inc. and Receives Purchase Order

07/11/2018 - 13:30

VANCOUVER, British Columbia , Nov. 07, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ”), is pleased to announce the completion of a Definitive Agreement (“ [...]

Grupo Natac S.L. and Radient Technologies Launch Natac Solutions at SupplySide West

07/11/2018 - 13:30

Advanced-Efficacy Extracts Offer Condition-Specific Functional Benefits EDMONTON, Alberta and MADRID, Spain, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (TSX Venture: RTI) and Grupo Natac S.L. (Natac) [...]

TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2018 Financial Results and Business Update

07/11/2018 - 13:30

Investor Conference Call to be held, Friday, November 9, 2018 at 8:30 AM ET NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Friday, [...]

XOMA Announces Proposed Rights Offering

07/11/2018 - 13:05

Rights Offering will be available to all shareholders of record on November 16, 2018 $20 million to be raised Fully backstopped by BVF Partners L.P. EMERYVILLE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation [...]

Summit Therapeutics to Participate in Jefferies 2018 London Healthcare Conference

07/11/2018 - 13:00

Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Participate in Jefferies 2018 London Healthcare Conference Oxford, UK, and Cambridge, MA, US, 7 November 2018 – Summit Therapeutics plc (NASDAQ [...]